Most recently, Mr Landau has served as vice president of business development and marketing planning and member of the senior management team at Tengion, a regenerative medicine company.
Prior to Tengion, Mr Landau was with Cordis, Johnson & Johnson’s interventional cardiology franchise, where he served as executive director of new business development.
William Edelman, president and CEO for Tyrx, said: “George brings to Tyrx a business development capability uniquely suited to our growing presence in implantable combination drug/device products. George’s clear track record of building successful, value creating transactions will accelerate our trajectory as an innovative leader in the medical device industry.”